ARTICLE | Clinical News
J&J, Eli Lilly report Phase III results
June 15, 2001 7:00 AM UTC
JNJ and LLY said Phase III data in 16,588 acute myocardial infarction patients published in The Lancet showed that ReoPro abciximab in combination with Retavase reteplase was not inferior to Retavase ...